AKT1 and breast carcinoma: However, inducible systemic Akt1 deletion after tumour initiation, but not cell-autonomous Akt1 ablation, inhibited metastasis in HER2-enriched mouse models of breast cancer by impairing neutrophil mobilisation [26].